ADHD medication dispensing increased steeply in Norway during 2020-2022, especially among females and young adults. The pattern suggests a marked shift in ADHD pharmacological treatment, and the shift is not mirrored by comparable increases in dispensing of other psychotropic drug groups or in recorded public outpatient activity.
Anker et al. (Fri,) studied this question.